Efficacy of JAK Inhibitors versus DMARDs in the Treatment of Polymyalgia Rheumatica in China

OBJECTIVE: This retrospective analysis was to assess the role of Janus kinases (JAK) inhibitors compared with conventional disease modifying anti-rheumatic drugs (DMRADs) in the treatment of polymyalgia rheumatica (PMR) with glucocorticoids (GCs) reduction. METHODS: Clinical information was collecte...

Descripción completa

Detalles Bibliográficos
Autores principales: Gu, Juanfang, Yang, Mingfeng, Zhang, Bin, Wang, Hongzhi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10350461/
https://www.ncbi.nlm.nih.gov/pubmed/37465555
http://dx.doi.org/10.2147/IJGM.S414267

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10350461/
https://www.ncbi.nlm.nih.gov/pubmed/37465555
http://dx.doi.org/10.2147/IJGM.S414267

Ejemplares similares